TheProfitWatch

NRXP - NRX Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.1 0.07 (2.26%) --- --- 0.0 (0.0%) 0.09 (2.9%) 0.05 (1.61%) 0.0 (0.0%) 0.0 (0.0%)

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.98
Diluted EPS:
Basic P/E:
-3.2347
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
3.17
RVol:

Events

Period Kind Movement Occurred At

Related News